Dr Mark Diamond, MD in Kensington, MD - Pediatrics

Dr Mark Diamond, MD is a Pediatrics physician based in Kensington, Maryland. Dr Mark Diamond is licensed to practice in Pennsylvania (license number MD018122E) and his current practice location is 2665 Mccomas Ave, Kensington, Maryland. He can be reached at his office (for appointments etc.) via phone at (412) 341-7288.

NPI number for Dr Mark Diamond is 1952304537 and his current mailing address is 2665 Mccomas Ave, Kensington, Maryland. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1952304537.

Contact Information

	Dr Mark Diamond, MD
	2665 Mccomas Ave, Kensington, MD 20895-2826
	(412) 341-7288
	Not Available

Physician's Profile

Full Name	Dr Mark Diamond
Gender	Male
Speciality	Pediatrics
Location	2665 Mccomas Ave, Kensington, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1952304537
Provider Enumeration Date: 05/27/2005
Last Update Date: 04/26/2023

Medical Identifiers

Medical identifiers for Dr Mark Diamond such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952304537	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	MD018122E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Mark Diamond is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Mark Diamond, MD 2665 Mccomas Ave, Kensington, MD 20895-2826 Ph: (412) 341-7288	Dr Mark Diamond, MD 2665 Mccomas Ave, Kensington, MD 20895-2826 Ph: (412) 341-7288

News Archive

VR found to be effective in reducing perceived pain during exercise

The research, led by PhD candidate Maria Matsangidou from EDA, set out to determine how using VR while exercising could affect performance by measuring a raft of criteria: heart rate, including pain intensity, perceived exhaustion, time to exhaustion and private body consciousness.

Study demonstrates efficacy of CONCERTA in treating ADHD in presence of comorbid learning disability

Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.

Researcher proposes simple, cost-effective tools for monitoring aerobic fitness

Although this system is already being used by professional sportspeople and teams, it cannot always be extended to amateur sportspeople or patients with limited economic resources because it requires supervision by qualified professionals.

GM-SCF therapy can reduce flu symptoms and prevent death

New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor significantly reduces flu symptoms and prevents death after a lethal dose influenza virus.

Pediatrics Doctors in Kensington, MD

Dr. Kozue Leone, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114
Dr. William Harold Neches, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5229 Strathmore Ave, Kensington, MD 20895 Phone: 240-475-4077 Fax: 240-303-2512
Bhavna Bali, MD. Pediatrics Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-821-7500 Fax: 661-250-5290
Dr. Kawaljeet K Chawla, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7507 Fax: 301-929-7114
Elizabeth Anne Valois, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kaiser Permanente Kensington Medical Center, Kensington, MD 20895 Phone: 301-929-3630
Dr. Laura V Rusch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7027
Dr. Carolyn L Avery, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114

Dr Mark Diamond, MD - Pediatrics in Kensington, MD